doi:10.3389/fnut.2024.1398059 Solomon SD, Ostrominski JW, Wang X, et al
The TRIUMPH-1 obesity trial ran to 80 weeks across 2,339 participants, with 65.3% of those on the 12 mg dose dropping below a BMI of 30
In clinical trials, adults who used Wegovy alongside diet and lifestyle changes lost an average of 1415% of their body weight over one year.* Individual results vary based on factors such as dosage, adherence, lifestyle habits, and overall health
It focuses on maintaining efficient energy production and supporting systems essential for overall vitality
Compounded GLP-1s are produced in FDA-registered facilities but have not been evaluated by the FDA for safety, efficacy or quality
The biggest word I can say to them is that I appreciate it and just thank them. ********************************************************************************************************************************************************** No